Why the study?
Somatic KCNJ5 variants commonly cause primary aldosteronism, but few patients develop the disease from germline variants in KCNJ5.
This case demonstrates that low-level germline mosaicism for a KCNJ5 variant can cause early-onset primary aldosteronism with bilateral adrenocortical hyperplasia, highlighting the utility of deep sequencing in unexplained cases.
I need the full paper and key finding before drafting the implication. Searching now.Found the paper. Pulling the full abstract and results next.The Ovid snippet has more of the abstract. Fetching the full text next.Do not assume negative blood DNA excludes KCNJ5 in childhood BAH; leaves open mosaicism as an underrecognized cause of early-onset PA.
BACKGROUND: Somatic variants in KCNJ5 are the most common cause of primary aldosteronism (PA). There are few patients with PA in whom the disease is caused by germline variants in the KCNJ5 potassium channel gene (familial hyperaldosteronism type III-FH-III). METHODS: A 5-year-old patient who developed hypertension due to bilateral adrenocortical hyperplasia (BAH) causing PA had negative peripheral DNA testing for any known genetic causes of PA. He was treated medically with adequate control of his PA but by the third decade of his life, due to worsening renal function, he underwent bilateral adrenalectomy. RESULTS: Focused exome sequencing in multiple nodules of his BAH uncovered a "hot-spot" pathogenic KCNJ5 variant, while repeated Sanger sequencing showed no detectable DNA defects in peripheral blood and other tissues. However, whole exome, "deep" sequencing revealed that 0.23% of copies of germline DNA did in fact carry the same KCNJ5 variant that was present in the adrenocortical nodules, suggesting low level germline mosaicism for this PA-causing KCNJ5 defect. CONCLUSIONS: Thus, this patient represents a unique case of BAH due to a mosaic KCNJ5 defect. Undoubtedly, his milder PA compared with other known cases of FH-III, was due to his mosaicism. This case has a number of implications for the prognosis, treatment, and counseling of the many patients with PA due to BAH that are seen in hypertension clinics.
No takes yet. Share an insight, caveat, or question.
Maria et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: